Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000727892 | SCV000855398 | likely benign | not specified | 2017-07-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001304883 | SCV001494188 | benign | not provided | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001304883 | SCV001822659 | likely benign | not provided | 2019-03-20 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002485852 | SCV002799115 | likely benign | Chondrodysplasia punctata 2 X-linked dominant; MEND syndrome | 2022-04-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001304883 | SCV004166212 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | EBP: BS2 |
Ambry Genetics | RCV004026936 | SCV004863297 | likely benign | Inborn genetic diseases | 2021-12-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |